LCN2 and nephrotic syndrome: The results of our study demonstrate that the concentration of NGAL in urine (expressed as a NGAL to creatinine ratio in the urine sample) cannot be used to detect early stages of CsA nephrotoxicity in children with nephrotic syndrome that is treated with this drug.